![]() |
市场调查报告书
商品编码
1871848
全球RNAi农药市场:预测至2032年-依产品、作物类型、配方、技术、应用、最终用户及地区进行分析RNAi Pesticides Market Forecasts to 2032 - Global Analysis By Product (Topical RNAi Pesticides, Seed-Embedded RNAi, Transgenic RNAi and Other Products), Crop Type, Formulation, Technology, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,预计 2025 年全球 RNAi 杀虫剂市场价值将达到 15.4 亿美元,到 2032 年将达到 33.8 亿美元,预测期内复合年增长率为 11.9%。
RNAi(RNA干扰)农药是一类新型生物农药,它利用基因静默技术靶向害虫生存和繁殖所必需的特定基因。这类农药透过引入与害虫基因组序列相符的双链RNA(dsRNA)分子发挥作用。害虫摄取dsRNA后,细胞内机制会降解相应的传讯RNA(mRNA),从而有效地「关闭」目标基因,干扰关键的生物过程。 RNAi农药具有高精度,并能减少对非目标物种和环境的危害。作为传统化学农药的永续替代方案,RNAi农药有助于在农业领域实现更安全、更精准的害虫防治。
标靶特异性高,脱靶毒性低
RNA干扰技术能够在不影响有益生物或週边生态系的情况下,实现害虫基因静默。平台技术利用分子标靶和可生物降解的製剂,支持对昆虫、杂草和病原体的选择性控制。将精密农业与法规结构和抗性管理结合,能够提高田间作业效率和合规性。商业农场、合作社和农业技术Start-Ups对安全、高效且环境友善的解决方案的需求日益增长。这些趋势正在推动下一代作物保护生态系统中平台技术的应用。
环境稳定性与野外持久性挑战
RNA分子易受紫外线照射、温度变化和微生物活动的影响而迅速降解,从而降低其在田间的持久性和有效性。企业在优化製剂递送和包封以提高其耐久性和吸收率方面面临许多挑战。缺乏标准化通讯协定和区域性能数据进一步加剧了实施难度和可靠性问题。供应商必须投资奈米载体、保护性涂层和缓释系统以提高稳定性。这些限制因素持续阻碍该平台在露天和气候敏感型农业地区的成熟。
对永续农业解决方案的需求日益增长
随着消费者和监管机构日益重视零残留、环境友善产品,基于RNAi技术的农药提供了一种精准的防治方法,最大限度地减少了对非目标物种和生态系统的损害。这些生物技术解决方案减少了对化学农药的依赖,并与全球措施永续和可再生农业倡议相契合。此外,RNAi农药能够长期有效控制害虫抗药性,在不损害土壤品质的前提下提高作物健康和产量。对永续农业实践的日益重视,以及政府对绿色技术的支持,正在进一步加速市场扩张。
药效因害虫种类和给药途径而异
不同害虫物种在敏感性、吸收和基因表现方面的差异,使得统一防治和剂量优化变得困难。企业在设计频谱或多标靶RNAi製剂时,既要确保其特异性,也要应对挑战。此外,给药方法缺乏标准化以及作物相容性不足,进一步限制了扩充性和营运效率。供应商必须提供模组化的害虫分析和自适应给药系统,以提高防治效果的一致性。这些限制因素持续限制该平台在多样化、多害虫农业环境中的表现。
疫情扰乱了RNAi农药研发的田间试验、供应链和监管合作。封锁措施延缓了产品检验、相关人员参与和商业化部署,同时增加了对永续、低残留作物保护的需求。公共和私营部门对遥感探测、数位农艺和分子生物学研发的投资激增。 RNAi平台作为扩充性、安全且精准的传统农药替代方案,正日益受到关注。政策制定者和消费者越来越关注食品安全、环境影响和生物材料。这些转变支持以RNAi技术为核心、注重韧性的农药基础设施进行长期投资。
预计在预测期内,RNAi局部喷雾剂细分市场将占据最大的市场份额。
由于其易于施用、吸收迅速且与现有农业实践相容,RNAi局部喷洒剂预计将在预测期内占据最大的市场份额。该平台支援透过叶面喷施递送RNA分子进行害虫防治,无需基因改造或系统性暴露。与无人机喷洒、智慧灌溉和气象追踪技术的结合可提高喷洒精度和覆盖范围。水果、蔬菜和高价值作物对非侵入性、灵活且无残留解决方案的需求日益增长。供应商提供即用型配方、常温包装和针对特定作物的通讯协定,以促进其应用。这些优势巩固了该细分市场在局部RNAi农药平台中的主导地位。
预计在预测期内,种子植入式RNAi技术细分市场将呈现最高的复合年增长率。
预计在预测期内,种子包埋RNAi技术将达到最高成长率,主要得益于该平台在苗前病虫害防治和系统性保护领域的拓展。 RNA分子被嵌入种子披衣或基质中,在种子萌发和早期生长阶段定序靶基因。此平台支援长期防治、减少施用频率,并可与种子处理流程无缝衔接。与作物遗传学、监管标籤和精准播种技术的整合,进一步提升了扩充性和合规性。谷物、豆类和工业作物对持久耐用、嵌入式解决方案的需求日益增长。这些趋势正在推动基于种子的RNAi农药平台和服务的发展。
由于监管合规、研究基础设施以及机构对美国农药技术的投资,预计北美将在预测期内保持最大的市场份额。各公司正在玉米、大豆和特种作物领域部署相关平台,以实现抗性管理和永续性目标。对分子生物学田间示范试验和美国环保署(EPA)合规性的投资,为创新和商业化提供了支持。主要供应商、学术机构和农业科技加速器的存在,正在促进生态系统的深化和应用。各公司正在调整其RNAi策略,使其符合美国农业部(USDA)的指令、环境、社会和治理(ESG)报告以及出口合规要求。这些因素共同推动了美国在RNAi农药的应用和管治的主导地位。
预计亚太地区在预测期内将呈现最高的复合年增长率,这主要得益于病虫害压力、作物多样性和数位农业在该地区经济中的融合。印度、中国、印尼和越南等国正在水稻、棉花和园艺作物中推广RNAi平台。政府支持计画正在推动生物技术孵化、永续投入品和农民教育,整体农业化学品创新。本地供应商正在提供经济高效、行动优先且符合当地文化的解决方案,以满足小规模农户和合作社的需求。都市区农业全部区域对扩充性、全面且无残留作物保护的需求日益增长。这些趋势正在推动亚太地区RNAi农业化学品创新和应用的成长。
According to Stratistics MRC, the Global RNAi Pesticides Market is accounted for $1.54 billion in 2025 and is expected to reach $3.38 billion by 2032 growing at a CAGR of 11.9% during the forecast period. RNAi (RNA interference) pesticides are a new class of biopesticides that use gene-silencing technology to control pests by targeting specific genes essential for their survival or reproduction. These pesticides work by introducing double-stranded RNA (dsRNA) molecules that match sequences in the pest's genome. When ingested, the pest's cellular machinery degrades the matching messenger RNA (mRNA), effectively "switching off" the target gene and disrupting vital biological processes. RNAi pesticides offer high precision, reducing harm to non-target species and the environment. They represent a sustainable alternative to conventional chemical pesticides, promoting safer and more targeted pest management in agriculture.
High target specificity & lower non-target toxicity
RNA interference enables gene silencing in pest species without affecting beneficial organisms or surrounding ecosystems. Platforms support selective control of insects weeds and pathogens using molecular targeting and biodegradable formulations. Integration with precision agriculture regulatory frameworks and resistance management enhances field performance and compliance. Demand for safe effective and environmentally aligned solutions is rising across commercial farms cooperatives and agtech startups. These dynamics are propelling platform deployment across next-generation pesticide ecosystems.
Environmental stability & field persistence issues
RNA molecules degrade rapidly under UV exposure temperature shifts and microbial activity which reduces field longevity and impact. Enterprises face challenges in optimizing formulation delivery and encapsulation to improve durability and uptake. Lack of standardized protocols and region-specific performance data further complicates adoption and trust. Vendors must invest in nanocarriers protective coatings and controlled release systems to enhance stability. These constraints continue to hinder platform maturity across open-field and climate-sensitive agricultural zones.
Growing demand for sustainable agriculture solutions
Consumers and regulatory bodies increasingly favor residue-free and environmentally safe products; RNAi-based pesticides provide a targeted approach that minimizes harm to non-target species and ecosystems. These biotechnological solutions help reduce chemical pesticide dependence, aligning with global initiatives for sustainable and regenerative farming. Moreover, RNAi pesticides offer long-term pest resistance management, enhancing crop health and productivity without compromising soil quality. The rising emphasis on sustainable farming practices, coupled with government support for green technologies, further accelerates the market's expansion.
Variable efficacy across pest species and delivery routes
Different pests exhibit varying sensitivity uptake and gene expression which complicates uniform control and dosage optimization. Enterprises face challenges in designing broad-spectrum or multi-target RNAi formulations without compromising specificity. Lack of delivery standardization and crop compatibility further limits scalability and operational efficiency. Vendors must offer modular design pest profiling and adaptive delivery systems to improve consistency. These limitations continue to constrain platform performance across diverse and multi-pest agricultural environments.
The pandemic disrupted field trials supply chains and regulatory engagement across RNAi pesticide development. Lockdowns delayed product validation stakeholder outreach and commercial rollout while increasing demand for sustainable and low-residue crop protection. Investment in remote sensing digital agronomy and molecular R&D surged across public and private sectors. RNAi platforms gained traction as scalable safe and precision-aligned alternatives to conventional pesticides. Public awareness of food safety environmental impact and biological inputs increased across policy and consumer circles. These shifts are reinforcing long-term investment in RNAi-enabled and resilience-focused pesticide infrastructure.
The topical RNAi sprays segment is expected to be the largest during the forecast period
The topical RNAi sprays segment is expected to account for the largest market share during the forecast period due to their ease of application rapid uptake and compatibility with existing farm practices. Platforms support foliar delivery of RNA molecules for pest suppression without genetic modification or systemic exposure. Integration with drone spraying smart irrigation and weather tracking enhances precision and field coverage. Demand for non-invasive flexible and residue-free solutions is rising across fruits vegetables and high-value crops. Vendors offer ready-to-use formulations shelf-stable packaging and crop-specific protocols to support adoption. These capabilities are boosting segment dominance across topical RNAi pesticide platforms.
The seed-embedded RNAi segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the seed-embedded RNAi segment is predicted to witness the highest growth rate as platforms expand across pre-emergent pest control and systemic protection. RNA molecules are embedded within seed coatings or matrices to deliver targeted gene silencing during germination and early growth. Platforms support long-duration control reduced application frequency and integration with seed treatment workflows. Integration with crop genetics regulatory labeling and precision planting enhances scalability and compliance. Demand for embedded durable and low-labor solutions is rising across cereals pulses and industrial crops. These dynamics are accelerating growth across seed-based RNAi pesticide platforms and services.
During the forecast period, the North America region is expected to hold the largest market share due to its regulatory engagement research infrastructure and institutional investment across RNAi pesticide technologies. Enterprises deploy platforms across corn soybean and specialty crop segments to meet resistance management and sustainability goals. Investment in molecular biology field validation and EPA alignment supports innovation and commercialization. Presence of leading vendor's academic institutions and agtech accelerators drives ecosystem depth and adoption. Firms align RNAi strategies with USDA mandates ESG reporting and export compliance. These factors are propelling North America's leadership in RNAi pesticide deployment and governance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as pest pressure crop diversity and digital agriculture converge across regional economies. Countries like India China Indonesia and Vietnam scale RNAi platforms across rice cotton and horticulture segments. Government-backed programs support biotech incubation sustainable inputs and farmer education across pesticide innovation. Local providers offer cost-effective mobile-first and culturally adapted solutions tailored to smallholder and cooperative needs. Demand for scalable inclusive and residue-free crop protection is rising across urban and rural agricultural zones. These trends are accelerating regional growth across Asia Pacific's RNAi pesticide innovation and deployment.
Key players in the market
Some of the key players in RNAi Pesticides Market include GreenLight Biosciences Inc., Syngenta AG, Bayer AG, Monsanto Company, Corteva Inc., AgBiome Inc., BioDirect Inc., Pioneer Hi-Bred International Inc., Vestaron Corporation, Precision BioSciences Inc., RNAissance Ag LLC, Evogene Ltd., Intrexon Corporation, Monsanto BioDirect and GreenVenus LLC.
In July 2025, Syngenta expanded its biologicals portfolio through the acquisition of Intrinsyx Bio, a biotech firm specializing in nature-based crop protection. The acquisition supported Syngenta's RNAi and biostimulant pipeline, reinforcing its commitment to sustainable farming and positioning it for leadership in the projected $20 billion biologicals market.
In May 2023, GreenLight Biosciences entered a definitive agreement to be acquired by a consortium led by Fall Line Endurance Fund in an all-cash transaction valued at $45.5 million. The go-private deal aimed to streamline operations and refocus resources on RNA pesticide commercialization and biomanufacturing scale-up.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.